Harvard University and Dana-Farber Cancer Institute Grant Acetylon Exclusive License to Breakthrough Discovery ... (Business Wire via Yahoo! Finance)

8 March 2010, 7:00 am

CAMBRIDGE, Mass.----Harvard University and Dana-Farber Cancer Institute announced today that they have concluded a major licensing agreement with Acetylon under which Harvard and Dana-Farber granted an exclusive therapeutic license to a robust platform technology and chemical methodology that enables high-throughput screening and lead optimization for HDAC inhibitor compounds.... Read More »

More Topics from "News"

• Tribune wins fairness award (Chicago Tribune)
• Tribune wins fairness award for Clout Goes to College expose (Chicago Tribune)
• BYU ranked most popular school in nation (KSL Salt Lake City)
• Community celebrates swim team's 16th big splash (Worcester Telegram & Gazette)
• BYU first, Harvard second on U.S. News & World Report's enrollment-percentage list (Deseret News)
• BYU ranks most popular university in U.S. (Provo Daily Herald)
• ZenBio Licenses Metabolic Cell Line from Harvard (GenomeWeb News)
• Gurus Go To Harvard (Forbes)
• Harvard, Dana-Farber License Screening Platform to Acetylon (GenomeWeb News)